Caitlin Burk, MD Duncan Morgan Bert Ruiter, PhD Qian Yuan, MD PhD J. Christopher Love, PhD Wayne Shreffler, MD PhD FAAAAI DOI:https://doi.org/10.1016/j.jaci.2021.12.025 Recent whole tissue RNA sequencing (RNAseq) and other bulk assays indicate that type I and II interferon responses are upregulated in active eosinophilic esophagitis (EoE), a Th2-biased inflammatory disease, but the cellular signaling network is unresolved.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Bert Ruiter
Reply
To the Editor: 1 Miller J.D. Potential role of advanced glycation end products in the TH2 adjuvant effect of peanut protein. J Allergy Clin Immunol. 2021; 148 () for his interest in our article “Peanut protein acts as a T We thank MillerH2 adjuvant by inducing RALDH2 in human antigen-presenting cells,” 2 Ruiter B. Smith N.P. Fleming E. Patil S.U. Hurlburt B.K. Maleki S.J. et al. Peanut protein acts as a TH2 adjuvant by inducing RALDH2 in human antigen-presenting cells. J Allergy Clin Immunol.
Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis
Pathogenic esophageal TH2 cells Eosinophilic esophagitis (EoE) is an allergic disease triggered by exposure to food-derived allergens and characterized by chronic type 2 esophageal inflammation. Morgan et al. examined tissue-specific immune responses underlying EoE using paired single-cell RNA and TCR sequencing of esophageal, peripheral blood, and duodenal samples collected from patients with EoE.
Transcriptomic and Gene Set Enrichment Analysis of Peanut stimulated CD4+ T cells during Peanut Oral Immunotherapy
Early studies suggest that oral immunotherapy (OIT) decreases Th2 cytokine production, a possible mechanism for desensitization. However, data remains limited on the differences between individuals who develop transient desensitization (TD) versus sustained unresponsiveness (SU), a longer-lasting protection after OIT. Article Info Publication History Identification DOI: https://doi.org/10.1016/j.jaci.2020.12.588 Copyright © 2020 Published by Elsevier Inc.
Peanut protein acts as a TH2 adjuvant by inducing RALDH2 in human antigen-presenting cells
Background Peanut is a potent inducer of proallergenic TH2 responses in susceptible individuals. Antigen-presenting cells (APCs) including dendritic cells and monocytes instruct naive T cells to differentiate into various effector cells, determining immune responses such as allergy and tolerance.
Expansion of the CD4+ effector T cell repertoire characterizes peanut-allergic patients with heightened clinical sensitivity
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Abstract Background Individuals with peanut allergy range in clinical sensitivity: some can consume grams of peanut before experiencing any symptoms, while others suffer systemic reactions to 10 mg or less. Current diagnostic testing only partially predicts this clinical heterogeneity.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Bert
Contact Bert, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack